These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18670212)

  • 1. Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis.
    Potula R; Ramirez SH; Knipe B; Leibhart J; Schall K; Heilman D; Morsey B; Mercer A; Papugani A; Dou H; Persidsky Y
    AIDS; 2008 Aug; 22(13):1539-49. PubMed ID: 18670212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.
    Omeragic A; Hoque MT; Choi UY; Bendayan R
    J Neuroinflammation; 2017 Sep; 14(1):183. PubMed ID: 28886715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes.
    Ramirez SH; Heilman D; Morsey B; Potula R; Haorah J; Persidsky Y
    J Immunol; 2008 Feb; 180(3):1854-65. PubMed ID: 18209083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects.
    Hayes MM; Lane BR; King SR; Markovitz DM; Coffey MJ
    J Biol Chem; 2002 May; 277(19):16913-9. PubMed ID: 11847231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.
    Necela BM; Su W; Thompson EA
    Immunology; 2008 Nov; 125(3):344-58. PubMed ID: 18422969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects.
    Skolnik PR; Rabbi MF; Mathys JM; Greenberg AS
    J Acquir Immune Defic Syndr; 2002 Sep; 31(1):1-10. PubMed ID: 12352144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARγ signaling in human THP-1 macrophages.
    Xu L; Shen S; Ma Y; Kim JK; Rodriguez-Agudo D; Heuman DM; Hylemon PB; Pandak WM; Ren S
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E788-99. PubMed ID: 22275753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands.
    Bardelli C; Amoruso A; Federici Canova D; Fresu L; Balbo P; Neri T; Celi A; Brunelleschi S
    Br J Pharmacol; 2012 Feb; 165(3):716-28. PubMed ID: 21745193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco smoke affects expression of peroxisome proliferator-activated receptor-gamma in monocyte/macrophages of patients with coronary heart disease.
    Amoruso A; Gunella G; Rondano E; Bardelli C; Fresu LG; Ferrero V; Ribichini F; Vassanelli C; Brunelleschi S
    Br J Pharmacol; 2009 Nov; 158(5):1276-84. PubMed ID: 19814730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development.
    Takahashi Y; Hasegawa-Moriyama M; Sakurai T; Inada E
    Anesth Analg; 2011 Aug; 113(2):398-404. PubMed ID: 21490083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.
    Wakui Y; Inoue J; Ueno Y; Fukushima K; Kondo Y; Kakazu E; Obara N; Kimura O; Shimosegawa T
    Biochem Biophys Res Commun; 2010 May; 396(2):508-14. PubMed ID: 20430009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARγ agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages.
    Yin Y; Hou G; Li E; Wang Q; Kang J
    Respir Res; 2014 Mar; 15(1):28. PubMed ID: 24612634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ishii N; Matsumura T; Kinoshita H; Fukuda K; Motoshima H; Senokuchi T; Nakao S; Tsutsumi A; Kim-Mitsuyama S; Kawada T; Takeya M; Miyamura N; Nishikawa T; Araki E
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model.
    Omeragic A; Kara-Yacoubian N; Kelschenbach J; Sahin C; Cummins CL; Volsky DJ; Bendayan R
    Sci Rep; 2019 Jul; 9(1):9428. PubMed ID: 31263138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ activation suppresses the expression of MMP9 by downregulating NF-κB post intracerebral hemorrhage.
    Luo X; Wu J; Wu G
    Neurosci Lett; 2021 May; 752():135770. PubMed ID: 33636289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.